Ana Blasco (A Blasco Cordellat)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Patient Reported Outcomes

Clinical Practice

Peritoneal Dialysis

Advanced Non Small Cell Lung Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

This page only lists publications with an associated author ORCID identifier.

Publications

Ernest Nadal, Delvys Rodriguez Abreu, Marta Simó, Bartomeu Massuti, Oscar Juan Vidal, Gerardo Huidobro, Rafael López-Castro, Javier De Castro Carpeño, Anna Estival Gonzalez, Joaquín Mosquera, Ivana G Sullivan, Enriqueta Felip Font, Ana Blasco, Maria Guirado, Eva Pereira, Noelia Vilariño, Valentín Navarro, Jordi Bruna
Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Yolanda Escobar, Ramón de Las Peñas, J Perez Altozano, S Ros Martínez, A Sabino Álvarez, Ana Blasco, Elena María Brozos Vázquez, Jesus Corral, Ignacio Garcia-Escobar, Carmen Beato
SEOM clinical guidelines for anaemia treatment in cancer patients (2020). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 23 (5) (2021)
Ning Dong, Andrea Moreno-Manuel, Silvia Calabuig-Fariñas, Sandra Gallach, Feiyu Zhang, Ana Blasco, Francisco Aparisi, Marina Meri-Abad, Ricardo Guijarro, Rafael Sirera, Carlos Camps, Eloísa Jantus-Lewintre
Characterization of Circulating T Cell Receptor Repertoire Provides Information about Clinical Outcome after PD-1 Blockade in Advanced Non-Small Cell Lung Cancer Patients. Cancers 13 (12) (2021)